American journal of obstetrics and gynecology · 2019
Chronic hypertension in pregnancy.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Battarbee Ashley N, Sinkey Rachel G, Harper Lorie M, Oparil Suzanne, Tita Alan T N
Аннотация
Chronic hypertension and associated cardiovascular disease are among the leading causes of maternal and perinatal morbidity and death in the United States. Chronic hypertension in pregnancy is associated with a host of adverse outcomes that include preeclampsia, cesarean delivery, cerebrovascular accidents, fetal growth restriction, preterm birth, and maternal and perinatal death. There are several key issues related to the diagnosis and management of chronic hypertension in pregnancy where data are limited and further research is needed. These challenges and recent guidelines for the management of chronic hypertension are reviewed. Well-timed pregnancies are of utmost importance to reduce the risks of chronic hypertension; long-acting reversible contraceptive options are preferred. Research to determine optimal blood pressure thresholds for diagnosis and treatment to optimize short- and long-term maternal and perinatal outcomes should be prioritized along with interventions to reduce extant racial and ethnic disparities.
Предметные рубрики MeSH
Adrenergic alpha-2 Receptor AgonistsAdrenergic beta-AntagonistsAntihypertensive AgentsCalcium Channel BlockersCesarean SectionChronic DiseaseDelivery, ObstetricDisease ManagementFemaleFetal Growth RetardationGestational AgeHumansHypertensionLong-Acting Reversible ContraceptionMethyldopaPostnatal CarePre-EclampsiaPreconception CarePregnancyPregnancy Complications, CardiovascularPremature BirthPrenatal CareSeverity of Illness IndexSodium Potassium Chloride Symporter InhibitorsTime FactorsVasodilator Agents